Although the responsiveness to calcitriol treatment could be associated with not only the molecular subtype but also the vitamin D receptor (VDR) expression in breast cancer cells, considering that the VDR expression of breast cancer cell lines in our study was verified in previous studies [47,48]. The gene discussed is VDR; the disease is breast carcinoma.